Cartesian Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+1.22 M	99.7%	$0.56	+$689 K
Sells	2	-3.64 K	0.3%	$1.06	-$3.86 K
Net	-1	+1.22 M	99.4%		+$685 K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Timothy A. Springer	Director, 10%+ Owner	$56.4 M	+$689 K	+1.24%	Jul 2, 2024
Carsten Brunn	President and CEO, Director	$14.8 M	-$3.11 K	-0.02%	Jan 2, 2024
Blaine Davis	Chief Financial Officer	$7.45 M			Jan 2, 2024
Murat Kalayoglu	Director, 10%+ Owner	$5.18 M			Apr 8, 2024
Elizabeth Hoge	10%+ Owner	$5.17 M			Apr 8, 2024
Timothy C. Barabe	Director	$1.06 M			Jan 2, 2024
Carrie Smith Cox	Director	$1 M			Jan 2, 2024
Peter G. Traber	Chief Medical Officer	$931 K	-$747	-0.08%	Sep 25, 2023
Lloyd P. Johnston	Chief Operations Officer	$922 K			Jan 4, 2023
Zenner Patrick J	Director	$661 K			Jan 2, 2024
Nishan DeSilva	Director	$561 K			Jan 2, 2024
Aymeric Sallin	Director	$547 K			Jan 2, 2024
Takashi Kei Kishimoto	Chief Scientific Officer	$464 K			May 30, 2023
Kevin Tan	Chief Financial Officer	$427 K			Jan 3, 2022
Michael Singer	Director	$353 K			Apr 8, 2024
Christopher Jewell	Chief Scientific Officer	$150 K			Apr 8, 2024
Milos Miljkovic	Chief Medical Officer	$94.2 K			Apr 8, 2024
Metin Kurtoglu	Chief Technology Officer	$85.8 K			Apr 8, 2024
Goran Ando	Director	$59.3 K			Jan 2, 2023
Emily English	SVP, Head of Manufacturing	$26.7 K			Apr 9, 2024
Kemal Malik	Director	$14.7 K			Jul 1, 2024
Ann K. Donohue	VP Finance	$8.63 K			May 27, 2021
Scott Dunseth Myers	Director				Nov 13, 2023

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership